The Current Ratio as of December 2025 (TTM) for BiVictriX Therapeutics Plc (BVX.L) is 6.12

According to BiVictriX Therapeutics Plc’s latest financial reports and current stock price. The company's current Current Ratio is 6.12. This represents a change of -11.01% compared to the average of 6.88 of the last 4 quarters.

BiVictriX Therapeutics Plc (BVX.L) Historical Current Ratio (quarterly & annually)

How has BVX.L Current Ratio performed in the past?

The mean historical Current Ratio of BiVictriX Therapeutics Plc over the last ten years is 11.50. The current 6.12 Current Ratio has changed 5.22% with respect to the historical average. Over the past ten years (40 quarters), BVX.L's Current Ratio was at its highest in in the December 2020 quarter at 23.25. The Current Ratio was at its lowest in in the June 2021 quarter at 1.69.

BiVictriX Therapeutics Plc (BVX.L) Current Ratio by Quarter and Year

Discovering the peaks and valleys of BiVictriX Therapeutics Plc Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

BiVictriX Therapeutics Plc (BVX.L) Average Current Ratio

How has BVX.L Current Ratio performed in the past?

The current Current Ratio of BiVictriX Therapeutics Plc (BVX.L) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

BiVictriX Therapeutics Plc (BVX.L) Current Ratio vs. Peers

How is BVX.L’s Current Ratio compared to its peers?

BiVictriX Therapeutics Plc’s Current Ratio is greater than Induction Healthcare Group PLC (1.83), greater than Celadon Pharmaceuticals Plc (2.62), greater than MGC Pharmaceuticals Limited (0.19), less than Synairgen plc (9.01), greater than Advanced Oncotherapy plc (1.91), greater than Theracryf Plc (3.11), greater than NetScientific plc (0.38), less than Destiny Pharma plc (9.89), greater than Cambridge Nutritional Sciences plc (3.62), greater than ReNeuron Group plc (2.05),

Build a custom stock screener for BiVictriX Therapeutics Plc (BVX.L) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BiVictriX Therapeutics Plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

BiVictriX Therapeutics Plc (BVX.L) and other stocks custom spreadsheet templates

The easiest way to analyze a company like BiVictriX Therapeutics Plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.